Environmental Mutagenesis & Genomics Society

50th Annual Meeting, Washington DC

September 19-23, 2019 - Capital Hilton Washington DC

Environmental Mutagenesis and Genomics: The Next Fifty Years

 Important Dates

Registration

3/4/19-Registration is now Open
7/27/19-Early Bird Registration Ends
8/19/19-Advanced Registration Ends

Abstracts

2/22/19-Abstract Submission is now Open
5/1/19-Abstract Submission Deadline
8/29/19-Late Abstracts Deadline

Travel Awards

Travel Award Form Available
5/1/19-Travel Award Deadline

Hotel Information

2/27/19-Reservations Open
8/21/19-Reservation Deadline


EMGS Welcomes You

The EMGS welcomes members and attendees from across the US and around the world. Our diversity is essential to our success, and as your national professional society, we are committed to providing a safe and supportive forum for the communication of world-class science. The EMGS Diversity and Inclusion committee sends a special welcome to members of the LGBT community.  Please reach out to any member of the EMGS Diversity and Inclusion Committee with your comments.

Monday, September 23, 2019

7:00 AM - 8:00 AM

Committee Meeting

Hollaender Outreach
Committee Meeting

Diversity and Inclusion
Committee Meeting

Publication Policy

8:30 - 9:30 AM

Keynote:

Clinical Computational Oncology for Precision Cancer Medicine

Eliezer Van Allen, Broad Institute of MIT and Harvard, Cambridge, MA, USA

10:00 AM - 12:00 PM

Carcinogenic Potential of Glyphosate-Based Herbicides: Human, Animal and Mechanistic Evidence

Co-Chairs: Margaret Pratt, US EPA, Luoping Zhang, University of California, Berkeley, CA, USA


TBA

 

Mutation Rates and Evolution

Co-Chairs: Rosalie Elespuru, US FDA, Joann Sweasy, Yale University, New Haven, CT, USA


TBA

 

Platform


TBA

12:00 - 1:15 PM

Special Interest Group Meeting

Committee Meeting

Committee Meeting

1:30 - 3:30 PM

DNA repair: The Next 50 years

Co-Chairs: Patricia Opresko, University of Pittsburgh, PA, USA, Ashwaya Prakash, University of South Alabama Mitchell Cancer Institute, USA


TBA                      
Patricia Opresko, University of Pittsburgh, PA, USA

TBA                      
Steve West, The Francis Krick Institute, United Kingdom

TBA                      
Thomas Helleday, Karolinska Institutet, Sweden

TBA                      
Wei Yang, NIH/DI

TBA                      
From Abstracts

DNA as a Biomarker of Human Health: Associations Between Human Mutagenesis and Genomic Instability with Disease and Implications for Regulatory Testing

Co-Chairs: Kristine Witt, DNTP/NIEHS, Clint Valentine, TwinStrand Biosciences


TBA

 


Platform


TBA